瑞士干细胞产品的研发由 IFCTP 领导。随着美国和欧洲细胞治疗研发实验室和研究所的合并，美国和欧洲细胞治疗专业人员国际联合会成立。 IFCTP 自豪地介绍了新一代细胞疗法——诱导多能干细胞 (iPSC)。
我们的国际联合会致力于通过促进器官疗法和 iPSC 移植的临床研究以及与抗衰老领域公认的医学专业人士和社会合作，改善和加强对慢性退行性疾病和老年疾病患者的医疗保健和预防医学。
我们的国际联合会旨在为医疗和保健专业人员及其患者提供有关器官提取物和细胞疗法领域的技术和临床进展的最新和资源丰富的信息
Naturally, the first technique involved freezing the cells in order to retain living cells. For cells to remain stable, the ideal freezing temperature is roughly -80C. They are frozen for a maximum of three months, after which degeneration occurs.
The next step involves freezing the cells in liquid nitrogen at -196C to stop early cell deterioration.
However, there was a significant amount of risk, discomfort, and expense associated with the transportation and storage (logistics) of these frozen cells. From the production lab that may be located abroad, to the forwarding firm, the exporting country’s customs screening, the importing company, and finally, the clinics and hospitals. The aforementioned requires a significant
在到达最终用户之前，在运输或储存过程中的任何时候都不能将细胞从冷冻中取出或解冻。任何马虎或粗心的处理都会导致细胞严重降解或完全丧失功效。
